Tibet Duo Rui Pharmaceutical Co., Ltd.

¥46.00As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301075Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR 4.70%
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.92
PE TTM —
TSR TTM (18.11%)
Mkt cap ¥3.680B
ROIC (6.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥44
(3.55%)
(55.22%)
Hold 4|12|9|1|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.65
0.69
0.74
0.78
21.75%
22.45%
21.49%
25.60%
Revenue¥M
175.2
172.5
173.3
180.6
5.45%
0.18%
(3.28%)
3.23%
Peers (US$551.6M)
Cap (US$)
PE
548.8M
19.00x
552.2M
149.0x
Capital
TTM
5Y
10Y
Leveragex
0.586
0.065
0.058
EBIT/Intx
11.76
0.370
0.327
Own earn%
(161.68)
52.44
61.25
Sh yield%
37.33
9.84
12.11
Owners
Insiders/Inst%
8.49
85.85
Short interest%
5.41
SBC / revenue%
1.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
11–15
$1 testx
1.5
Incr. ROIC%
45